Login / Signup

Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome.

Christopher V AlmarioSamuel EberleinCarine KhalilBrennan M R Spiegel
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
The vast majority of patients with IBS experience breakthrough pain, and when selecting among therapies, they prioritize efficacy and most are willing to use a rapid-acting SQ treatment. These results support development of novel, effective medications-oral or SQ-for management of acute pain attacks.
Keyphrases